vs
e.l.f. Beauty, Inc.（ELF）与Bio-Techne（TECH）财务数据对比。点击上方公司名可切换其他公司
e.l.f. Beauty, Inc.的季度营收约是Bio-Techne的1.6倍（$489.5M vs $311.4M），Bio-Techne净利率更高（16.4% vs 8.0%，领先8.3%），e.l.f. Beauty, Inc.同比增速更快（37.8% vs -1.5%）
e.l.f. Beauty是美国知名彩妆品牌，2004年创立，总部位于加利福尼亚州奥克兰。品牌产品线丰富，涵盖沐浴护肤产品、矿物彩妆、专业美妆工具、眼线笔、口红、腮红、睫毛膏等多个品类，产品销往全球18个国家，入驻Target、沃尔玛等主流零售渠道，过半营收来自品牌官网。
Bio-Techne是美国头部生命科学企业，面向科研、诊断及生物工艺市场需求，研发、生产并销售生命科学试剂、仪器及配套服务，产品及解决方案广泛应用于基础研究、体外诊断、生物医药研发生产等场景，可为相关领域从业者提供可靠的专业工具支持。
ELF vs TECH — 直观对比
营收规模更大
ELF
是对方的1.6倍
$311.4M
营收增速更快
ELF
高出39.3%
-1.5%
净利率更高
TECH
高出8.3%
8.0%
损益表 — Q3 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $489.5M | $311.4M |
| 净利润 | $39.4M | $51.0M |
| 毛利率 | 71.0% | 66.9% |
| 营业利润率 | 13.8% | 24.2% |
| 净利率 | 8.0% | 16.4% |
| 营收同比 | 37.8% | -1.5% |
| 净利润同比 | 128.1% | 126.0% |
| 每股收益（稀释后） | $0.65 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ELFTECH
| Q1 26 | — | $311.4M | ||
| Q4 25 | $489.5M | $295.9M | ||
| Q3 25 | $343.9M | — | ||
| Q2 25 | $353.7M | $317.0M | ||
| Q1 25 | — | $316.2M | ||
| Q4 24 | — | $297.0M | ||
| Q3 24 | — | $289.5M | ||
| Q2 24 | — | $306.1M |
净利润ELFTECH
| Q1 26 | — | $51.0M | ||
| Q4 25 | $39.4M | $38.0M | ||
| Q3 25 | $3.0M | — | ||
| Q2 25 | $33.3M | $-17.7M | ||
| Q1 25 | — | $22.6M | ||
| Q4 24 | — | $34.9M | ||
| Q3 24 | — | $33.6M | ||
| Q2 24 | — | $40.6M |
毛利率ELFTECH
| Q1 26 | — | 66.9% | ||
| Q4 25 | 71.0% | 64.6% | ||
| Q3 25 | 69.4% | — | ||
| Q2 25 | 69.1% | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% |
营业利润率ELFTECH
| Q1 26 | — | 24.2% | ||
| Q4 25 | 13.8% | 18.4% | ||
| Q3 25 | 2.2% | — | ||
| Q2 25 | 13.8% | -7.5% | ||
| Q1 25 | — | 12.2% | ||
| Q4 24 | — | 16.0% | ||
| Q3 24 | — | 13.8% | ||
| Q2 24 | — | 15.0% |
净利率ELFTECH
| Q1 26 | — | 16.4% | ||
| Q4 25 | 8.0% | 12.8% | ||
| Q3 25 | 0.9% | — | ||
| Q2 25 | 9.4% | -5.6% | ||
| Q1 25 | — | 7.1% | ||
| Q4 24 | — | 11.7% | ||
| Q3 24 | — | 11.6% | ||
| Q2 24 | — | 13.3% |
每股收益（稀释后）ELFTECH
| Q1 26 | — | $0.32 | ||
| Q4 25 | $0.65 | $0.24 | ||
| Q3 25 | $0.05 | — | ||
| Q2 25 | $0.58 | $-0.11 | ||
| Q1 25 | — | $0.14 | ||
| Q4 24 | — | $0.22 | ||
| Q3 24 | — | $0.21 | ||
| Q2 24 | — | $0.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $196.8M | $209.8M |
| 总债务越低越好 | $816.7M | — |
| 股东权益账面价值 | $1.2B | $2.1B |
| 总资产 | $2.3B | $2.6B |
| 负债/权益比越低杠杆越低 | 0.70× | — |
8季度趋势，按日历期对齐
现金及短期投资ELFTECH
| Q1 26 | — | $209.8M | ||
| Q4 25 | $196.8M | $172.9M | ||
| Q3 25 | $194.4M | — | ||
| Q2 25 | $170.0M | $162.2M | ||
| Q1 25 | — | $140.7M | ||
| Q4 24 | — | $177.5M | ||
| Q3 24 | — | $187.5M | ||
| Q2 24 | — | $152.9M |
总债务ELFTECH
| Q1 26 | — | — | ||
| Q4 25 | $816.7M | $260.0M | ||
| Q3 25 | $831.6M | — | ||
| Q2 25 | $256.7M | $346.0M | ||
| Q1 25 | — | $330.0M | ||
| Q4 24 | — | $300.0M | ||
| Q3 24 | — | $300.0M | ||
| Q2 24 | — | $319.0M |
股东权益ELFTECH
| Q1 26 | — | $2.1B | ||
| Q4 25 | $1.2B | $2.0B | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $804.9M | $1.9B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $2.1B | ||
| Q3 24 | — | $2.1B | ||
| Q2 24 | — | $2.1B |
总资产ELFTECH
| Q1 26 | — | $2.6B | ||
| Q4 25 | $2.3B | $2.5B | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $1.3B | $2.6B | ||
| Q1 25 | — | $2.6B | ||
| Q4 24 | — | $2.7B | ||
| Q3 24 | — | $2.7B | ||
| Q2 24 | — | $2.7B |
负债/权益比ELFTECH
| Q1 26 | — | — | ||
| Q4 25 | 0.70× | 0.13× | ||
| Q3 25 | 0.73× | — | ||
| Q2 25 | 0.32× | 0.18× | ||
| Q1 25 | — | 0.16× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.14× | ||
| Q2 24 | — | 0.15× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $59.4M | — |
| 自由现金流经营现金流 - 资本支出 | $52.8M | — |
| 自由现金流率自由现金流/营收 | 10.8% | — |
| 资本支出强度资本支出/营收 | 1.4% | — |
| 现金转化率经营现金流/净利润 | 1.51× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ELFTECH
| Q1 26 | — | — | ||
| Q4 25 | $59.4M | — | ||
| Q3 25 | $23.4M | — | ||
| Q2 25 | $27.2M | $98.2M | ||
| Q1 25 | — | $41.1M | ||
| Q4 24 | — | $84.3M | ||
| Q3 24 | — | $63.9M | ||
| Q2 24 | — | $75.5M |
自由现金流ELFTECH
| Q1 26 | — | — | ||
| Q4 25 | $52.8M | — | ||
| Q3 25 | $16.6M | — | ||
| Q2 25 | $20.1M | $93.3M | ||
| Q1 25 | — | $31.0M | ||
| Q4 24 | — | $77.5M | ||
| Q3 24 | — | $54.7M | ||
| Q2 24 | — | $57.5M |
自由现金流率ELFTECH
| Q1 26 | — | — | ||
| Q4 25 | 10.8% | — | ||
| Q3 25 | 4.8% | — | ||
| Q2 25 | 5.7% | 29.4% | ||
| Q1 25 | — | 9.8% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 18.9% | ||
| Q2 24 | — | 18.8% |
资本支出强度ELFTECH
| Q1 26 | — | — | ||
| Q4 25 | 1.4% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 2.0% | 1.5% | ||
| Q1 25 | — | 3.2% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | — | 3.2% | ||
| Q2 24 | — | 5.9% |
现金转化率ELFTECH
| Q1 26 | — | — | ||
| Q4 25 | 1.51× | — | ||
| Q3 25 | 7.82× | — | ||
| Q2 25 | 0.82× | — | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | — | 2.42× | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | — | 1.86× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ELF
暂无分部数据
TECH
| Protein Sciences segment revenue | $226.2M | 73% |
| Diagnostics and Spatial Biology segment revenue | $85.6M | 27% |
| Other revenue (1) | $5.4M | 2% |
